Fingerprint
Dive into the research topics of 'Pembrolizumab for early triple-negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pembrolizumab for early triple-negative breast cancer
KEYNOTE-522 Investigators
Research output: Contribution to journal › Article › peer-review
1414
Scopus
citations